At a macro level, the quarter brought its share of challenges, with demand trends aligning closely with those seen in the first quarter. Persistent high food inflation continued to weigh on mass consumer spending. Internationally, political unrest in key markets, including Bangladesh, created some temporary disruptions. In the given context, the Company reported overall Revenues at ₹891 crore grew by 3% with Domestic Business growing by 2.6%. Major brands Navratna, Dermicool and Healthcare range and Pain Management range performed well. The company’s International Business demonstrated resilience amid geopolitical challenges, achieving a 12% sales growth excluding Bangladesh. Overall, the International Business expanded by 6% in both constant currency and INR terms during Q2, driven by strong performance in the MENA region. In the Q2FY25, gross margins increased by 60 basis points to 70.7%, while EBITDA grew by 7% to ₹250 crore, with margins expanding by 110 basis points to 28.1%. Profit Before Tax rose by 13% to ₹220 crore, accompanied by a 220 basis point margin expansion, and Profit After Tax surged by 19% to ₹213 crore.
Mr Harsha V Agarwal, Vice Chairman and Managing Director, Emami Limited said:We are pleased to close the first half of the year with strong performance, achieving 6% revenue growth, 10% EBITDA growth, and a 16% profit increase despite macroeconomic challenges. For H2 FY25, we expect stronger offtakes driven by improved rural demand and stable seasons ahead.
